Costa Rica Back In Business For Medical Research
Source: QuickSTAT
By Dave Murphym Regional Director of Life Sciences, U.S. Quick Group of Companies
Green light given to the continuation of clinical trials and medical research.
After 4 years of prohibition, Laura Chinchilla, President of the Republic of Costa Rica, signed new legislation on April 22, 2014, which allows the private, academic and public sector to once again produce new drugs and medical devices--a breakthrough for the scientific community in the country.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more